National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

From the 6/11/2021 release of VAERS data:

Found 332 cases where Vaccine is COVID19 and Symptom is Guillain-Barre syndrome



Case Details

This is page 10 out of 34

Result pages: prev   1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19   next


VAERS ID: 1138605 (history)  
Form: Version 2.0  
Age: 70.0  
Sex: Female  
Location: Unknown  
Vaccinated:2021-03-04
Onset:2021-03-16
   Days after vaccination:12
Submitted: 0000-00-00
Entered: 2021-03-26
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / UNK - / -

Administered by: Unknown       Purchased by: ?
Symptoms: Guillain-Barre syndrome
SMQs:, Peripheral neuropathy (narrow), Guillain-Barre syndrome (narrow), Demyelination (narrow), Immune-mediated/autoimmune disorders (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type:

Write-up: developed guillain-barre syndrome 2 weeks following 2nd vaccine administration. unclear if vaccine is the cause.


VAERS ID: 1141134 (history)  
Form: Version 2.0  
Age: 21.0  
Sex: Male  
Location: Michigan  
Vaccinated:2021-03-18
Onset:2021-03-25
   Days after vaccination:7
Submitted: 0000-00-00
Entered: 2021-03-28
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (MODERNA)) / MODERNA - / UNK - / -

Administered by: Unknown       Purchased by: ?
Symptoms: Guillain-Barre syndrome
SMQs:, Peripheral neuropathy (narrow), Guillain-Barre syndrome (narrow), Demyelination (narrow), Immune-mediated/autoimmune disorders (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type:

Write-up: Guillan Barre Syndrome


VAERS ID: 1144847 (history)  
Form: Version 2.0  
Age: 72.0  
Sex: Female  
Location: Virginia  
Vaccinated:2021-03-08
Onset:2021-03-15
   Days after vaccination:7
Submitted: 0000-00-00
Entered: 2021-03-29
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN - / 1 - / IM

Administered by: Unknown       Purchased by: ?
Symptoms: Guillain-Barre syndrome
SMQs:, Peripheral neuropathy (narrow), Guillain-Barre syndrome (narrow), Demyelination (narrow), Immune-mediated/autoimmune disorders (narrow)

Life Threatening? Yes
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: -Cognitive impairment -Hypercholesterolemia
Allergies: Penicillins
Diagnostic Lab Data:
CDC Split Type:

Write-up: Guillain Barre syndrome


VAERS ID: 1146222 (history)  
Form: Version 2.0  
Age: 61.0  
Sex: Male  
Location: Texas  
Vaccinated:2021-03-08
Onset:2021-03-23
   Days after vaccination:15
Submitted: 0000-00-00
Entered: 2021-03-30
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN 1805018 / N/A LA / IM

Administered by: Other       Purchased by: ?
Symptoms: Asthenia, Dysarthria, Facial paralysis, Fall, Gait inability, Guillain-Barre syndrome, Hypoaesthesia, Hypoaesthesia oral, Intensive care, Muscular weakness, Paralysis
SMQs:, Rhabdomyolysis/myopathy (broad), Peripheral neuropathy (narrow), Anticholinergic syndrome (broad), Dystonia (broad), Oropharyngeal conditions (excl neoplasms, infections and allergies) (narrow), Guillain-Barre syndrome (narrow), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Accidents and injuries (narrow), Demyelination (narrow), Conditions associated with central nervous system haemorrhages and cerebrovascular accidents (broad), Hearing impairment (broad), Hypoglycaemia (broad), Immune-mediated/autoimmune disorders (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, 5 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: Atorvastin Lisinopril Carvedilol
Current Illness: none
Preexisting Conditions: CHF
Allergies: NONE none
Diagnostic Lab Data: unit being monitored--- has been diagnosed with Guillian Barre syndrome awaiting test results and is to receive immunoglobulin intravenously. Possible unable to swallow without aspirating.
CDC Split Type:

Write-up: started getting numbness in hands-fingers and lips and then numbness to feet and fell to ground with inability to walk - no strength in legs knees or arms. left facial drooping and slurring of speech and severe weakness -paralyzed


VAERS ID: 1146686 (history)  
Form: Version 2.0  
Age: 49.0  
Sex: Female  
Location: Maryland  
Vaccinated:2021-03-18
Onset:2021-03-18
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2021-03-30
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (MODERNA)) / MODERNA - / 1 RA / OT

Administered by: Unknown       Purchased by: ?
Symptoms: Guillain-Barre syndrome, Hypoaesthesia, Paraesthesia, Vaccination site inflammation
SMQs:, Peripheral neuropathy (narrow), Guillain-Barre syndrome (narrow), Demyelination (narrow), Immune-mediated/autoimmune disorders (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: No adverse event (No medical history reported)
Allergies:
Diagnostic Lab Data:
CDC Split Type: USMODERNATX, INC.MOD20210

Write-up: Guillain-barre syndrome; Inflammation at the injection site; Tingling and numbness now spread to her finger tips; Tingling and numbness now spread to her finger tips; This spontaneous report was reported by a physician concerning a 49-years-old female patient who received mRNA-1273 (Moderna COVID-19 vaccine) and experienced Guillain-Barre syndrome, inflammation at the injection site and tingling and numbness now spread to her finger tips. The patient''s medical history was not provided. Concomitant product use was not provided by the reporter. On 18 Mar 2021, prior to onset of the events, the patient received first of two planned doses of mRNA-1273 (lot/batch number: unknown) intramuscularly in the right deltoid for prophylaxis of COVID-19 infection. On 18 Mar 2021, the patient experienced inflammation at the injection site, tingling and numbness now spread to her fingertips and might be developing medically significant event of Guillain-Barre syndrome. On 19 Mar 2021, increasing severity of tingling and numbness. Treatment for the events included ibuprofen. Action taken with mRNA-1273 in response to the events was not reported. The outcome of the events Guillain-Barre syndrome, inflammation at the injection site and tingling and numbness now spread to her finger tips was not reported.; Reporter''s Comments: Very limited information regarding this event/s has been provided at this time. Further information has been requested.


VAERS ID: 1148771 (history)  
Form: Version 2.0  
Age:   
Sex: Male  
Location: Pennsylvania  
Vaccinated:2021-02-25
Onset:2021-03-01
   Days after vaccination:4
Submitted: 0000-00-00
Entered: 2021-03-31
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EN6202 / 1 RA / -

Administered by: Unknown       Purchased by: ?
Symptoms: Asthenia, Blood creatinine, Blood glucose, Full blood count, Guillain-Barre syndrome, Haemoglobin, Metabolic function test, Paraesthesia
SMQs:, Peripheral neuropathy (narrow), Guillain-Barre syndrome (narrow), Demyelination (narrow), Immune-mediated/autoimmune disorders (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: TRULICITY; METOPROLOL [METOPROLOL FUMARATE]; ALOPURINOL; LIPITOR ORIFARM; ASPIRIN [ACETYLSALICYLIC ACID;ASCORBIC ACID]; VITAMIN D3; PROBIOTIC [BIFIDOBACTERIUM LACTIS]
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Cardiac disorder; Gastrointestinal disorder; Hypertension; Type 2 diabetes mellitus
Allergies:
Diagnostic Lab Data: Test Date: 20210313; Test Name: creatinine; Result Unstructured Data: Test Result:1.19; Comments: slightly elevated; Test Date: 20210313; Test Name: Blood Sugar; Result Unstructured Data: Test Result:140-160; Test Date: 20210313; Test Name: CBC; Result Unstructured Data: Test Result:good; Test Date: 20210313; Test Name: hemoglobin; Result Unstructured Data: Test Result:7.6; Comments: 7.6 out of range; Test Date: 20210313; Test Name: CMP; Result Unstructured Data: Test Result:all good
CDC Split Type: USPFIZER INC2021283872

Write-up: ascending bilateral symmetrical paresthesias in the legs to upper thighs and fingers of both hands; slight weakness; Guillain-Barre Syndrome; This is a spontaneous report from a contactable physician. A male patient of an unspecified age received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EN6202, expiration date: unknown), via an unspecified route of administration in right arm on 25Feb2021 at 15:30 as single dose for COVID-19 immunization. The patient''s medical history included hypertension, type 2 diabetes, and cardiac issues. Concomitant medication included dulaglutide (TRULICITY); metoprolol fumarate; alopurinol; atorvastatin calcium (LIPITOR ORIFARM); acetylsalicylic acid, ascorbic acid (ASPIRIN [ACETYLSALICYLIC ACID;ASCORBIC ACID]); vitamin d3; bifidobacterium lactis (PROBIOTIC [BIFIDOBACTERIUM LACTIS]), all ongoing for unspecified indication. The patient previously took Flu vaccine on an unspecified date for immunization. In Mar2021 (reported as after several days), the patient developed ascending bilateral symmetrical paresthesias in the legs to upper thighs and fingers of both hands peaking at 7-8 days and now slightly improving but persistent and associated with slight weakness suggesting Guillain-Barre Syndrome. The patient underwent lab tests and procedures which included blood creatinine: 1.19 (slightly elevated), blood sugar 140-160, complete blood count (CBC): good, haemoglobin: 7.6 (out of range), metabolic function test: all good on 13Mar2021. The patient did not received treatment for the events. The outcome of the events was recovering.; Sender''s Comments: Based on the current available information and the plausible drug-event temporal association, a possible contributory role of the suspect product BNT162B2 to the development of event Guillain-Barre syndrome cannot be excluded. The case will be reassessed if additional information becomes available. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.


VAERS ID: 1156573 (history)  
Form: Version 2.0  
Age: 58.0  
Sex: Male  
Location: Texas  
Vaccinated:2021-03-30
Onset:2021-03-30
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2021-04-01
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (MODERNA)) / MODERNA - / 1 - / -
COVID19: COVID19 (COVID19 (MODERNA)) / MODERNA - / 2 - / -

Administered by: Unknown       Purchased by: ?
Symptoms: C-reactive protein increased, Computerised tomogram head normal, Feeling abnormal, Guillain-Barre syndrome, Hypoaesthesia, Hyporeflexia, Muscular weakness, Myelitis transverse, Pain, Sensory loss
SMQs:, Rhabdomyolysis/myopathy (broad), Peripheral neuropathy (narrow), Dementia (broad), Guillain-Barre syndrome (narrow), Noninfectious encephalopathy/delirium (broad), Demyelination (narrow), Immune-mediated/autoimmune disorders (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: amLODIPine (NORVASC), atenoloL (Tenormin), garlic, ibuprofen
Current Illness:
Preexisting Conditions: Degenerative arthropathy, hyperlipidemia, hypertension, psoriasis, psoriatic arthritis, benign essential HTN
Allergies:
Diagnostic Lab Data:
CDC Split Type:

Write-up: Moderna COVID-19 Vaccine EUA Patient received Moderna second dose on 3/29/21 at 8:30 am and experienced weakness in legs later that day around 3:00 pm. Presented to emergency department on 3/30/21 with complaints of generalized body aches and numbness to both legs and lower arms, feeling like legs had fallen asleep. Initial examination in ED revealed sensory deficit with final diagnosis of myelitis, acute transverse and Guillain-Barre Syndrome after administration of vaccine. On 4/1/21, continuing to experience numbness with some ascending pattern, slight decrease in reflexes.


VAERS ID: 1159226 (history)  
Form: Version 2.0  
Age: 65.0  
Sex: Male  
Location: Michigan  
Vaccinated:2021-03-12
Onset:2021-03-23
   Days after vaccination:11
Submitted: 0000-00-00
Entered: 2021-04-02
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (MODERNA)) / MODERNA - / 2 - / IM

Administered by: Pharmacy       Purchased by: ?
Symptoms: Areflexia, Asthenia, Balance disorder, CSF protein increased, Guillain-Barre syndrome, Paraesthesia, White blood cell count increased
SMQs:, Peripheral neuropathy (narrow), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Guillain-Barre syndrome (narrow), Demyelination (narrow), Vestibular disorders (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Immune-mediated/autoimmune disorders (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, 5 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: Voltaren ointment
Current Illness:
Preexisting Conditions: None
Allergies: None
Diagnostic Lab Data: CSF: protein of 184, WBC 23 (mostly mononuclear). The elevated CSF WBC is uncommon, but reported in AIDP/GBS.
CDC Split Type:

Write-up: Slowly progressive tingling, imbalance, and mild weakness, with loss of reflexes, elevated CSF protein, and slightly elevated WBC in CSF. Current diagnosis is probable AIDP/GBS (Guillain Barre Syndrome) beginning about 12 days after vaccination. EXAM: Mild weakness, imbalance, absent reflexes in legs, trace biceps reflexes


VAERS ID: 1159663 (history)  
Form: Version 2.0  
Age: 84.0  
Sex: Male  
Location: Ohio  
Vaccinated:2021-02-26
Onset:2021-03-08
   Days after vaccination:10
Submitted: 0000-00-00
Entered: 2021-04-02
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (MODERNA)) / MODERNA 022M20A / 2 LA / SYR

Administered by: Private       Purchased by: ?
Symptoms: Asthenia, Computerised tomogram normal, Fall, Gait disturbance, Guillain-Barre syndrome, Hypoaesthesia, Immunoglobulin therapy, Lumbar puncture abnormal, Magnetic resonance imaging head normal, Magnetic resonance imaging spinal normal, Muscular weakness, Paraesthesia
SMQs:, Rhabdomyolysis/myopathy (broad), Peripheral neuropathy (narrow), Anticholinergic syndrome (broad), Parkinson-like events (broad), Guillain-Barre syndrome (narrow), Noninfectious encephalopathy/delirium (broad), Accidents and injuries (narrow), Demyelination (narrow), Hypoglycaemia (broad), Immune-mediated/autoimmune disorders (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit? Yes
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, 6 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: amlodipine, atorvastatin, hydrochlorothiazide, lisinopril, multivitamin, Vitamin D, CoQ10, Prostate Plus
Current Illness: None
Preexisting Conditions: High blood pressure and cholesterol controlled by medication
Allergies: None
Diagnostic Lab Data: To rule out a stroke, a CT scan and two MRI''s (of the head and spine) When a stroke was ruled out, a spinal tap was done to confirm the diagnosis of Guillain Barre Syndrome
CDC Split Type:

Write-up: Adverse events: Weakness in legs (had a fall), feeling of pins and needles in legs, feet and hands, loss of normal leg activity and strength, numbness in fingers, loss control of walking abilities Diagnosis: Guillain Barre Syndrome Treatment: 5 days of intravenous immunoglobulin Outcome: Don continues to slowly progress at home with therapy


VAERS ID: 1160481 (history)  
Form: Version 2.0  
Age: 59.0  
Sex: Female  
Location: Ohio  
Vaccinated:2021-02-26
Onset:2021-03-24
   Days after vaccination:26
Submitted: 0000-00-00
Entered: 2021-04-02
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (MODERNA)) / MODERNA 001A21A / 2 LA / IM

Administered by: Public       Purchased by: ?
Symptoms: CSF glucose increased, CSF protein increased, Guillain-Barre syndrome, Lumbar puncture
SMQs:, Peripheral neuropathy (narrow), Guillain-Barre syndrome (narrow), Demyelination (narrow), Immune-mediated/autoimmune disorders (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, 8 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: asa 81 mg novolog but truly not sure of what was being taken as had not seen pt in one yr
Current Illness: unknown
Preexisting Conditions: diabetes migraines ptsd depression morbid obseity
Allergies: pcn
Diagnostic Lab Data: spinal tap with elevated protein and sugar
CDC Split Type:

Write-up: Guillian Barre lower extremities


Result pages: prev   1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19   next

New Search

Link To This Search Result:

https://www.medalerts.org/vaersdb/findfield.php?EVENTS=ON&PAGENO=10&SYMPTOMS=Guillain-Barre_syndrome_%2810018767%29&VAX=COVID19


Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166